

Grindlays Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.86 Cr
- Satisfied Charges ₹ 9.60 Cr
- Revenue Growth 104.13%
- Profit Growth 165.52%
- Ebitda 69.53%
- Net Worth 49.54%
- Total Assets 39.34%
About Grindlays Pharmaceuticals
Grindlays Pharmaceuticals Pvt Ltd (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 September 1985 and has a history of 39 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.86 Cr. The company has closed loans amounting to ₹9.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Santosh Kolwankar, Ramkrishna Kolwankar, Dhanashri Gudi, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U99999MH1985PTC037368
- Company No.
037368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Grindlays Pharmaceuticals Pvt Ltd offer?
Grindlays Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Feed Additives, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Industrial Chemicals & Supplies, Aldehydes, Cardiovascular Drugs & Medication, Diabetes Medicine, API Intermediate, Etoricoxib Intermediate.
Who are the key members and board of directors at Grindlays Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramkrishna Kolwankar ![]() | Managing Director | 15-Oct-1985 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dhanashri Gudi ![]() | Director | 31-Mar-1995 | Current |
Santosh Kolwankar ![]() | Director | 16-Nov-2009 | Current |
Arti Kolwankar ![]() | Director | 01-Apr-1997 | Current |
Financial Performance of Grindlays Pharmaceuticals.
Grindlays Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 104.13% increase. The company also saw a substantial improvement in profitability, with a 165.52% increase in profit. The company's net worth Soared by an impressive increase of 49.54%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Grindlays Pharmaceuticals?
In 2022, Grindlays Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Chiplun Fine Chemicals Private Limited
Santosh Kolwankar is a mutual person
Charges (Loans)
₹5.86 Cr
₹9.60 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 5.86 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Sep 2008 | Bank Of India | ₹5.86 Cr | Open |
31 Jul 2013 | Deutsche Bank Ag | ₹3.55 Cr | Satisfied |
18 Mar 2009 | Bank Of India | ₹1.20 M | Satisfied |
27 Sep 2008 | Bank Of India | ₹3.50 Cr | Satisfied |
02 Aug 2004 | Bank Of India | ₹1.90 Cr | Satisfied |
How Many Employees Work at Grindlays Pharmaceuticals?
Grindlays Pharmaceuticals has a workforce of 12 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Grindlays Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grindlays Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Grindlays Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Grindlays Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Grindlays Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 18 Mar 2009 via Charge ID 10151901 with Bank Of India was fully satisfied on 14 Dec 2020.
- Charges
A charge registered on 27 Sep 2008 via Charge ID 10129799 with Bank Of India was fully satisfied on 14 Dec 2020.
- Charges
A charge registered on 02 Aug 2004 via Charge ID 90214119 with Bank Of India was fully satisfied on 14 Dec 2020.
- Charges
A charge registered on 31 Jul 2013 via Charge ID 10448577 with Deutsche Bank Ag was fully satisfied on 19 Nov 2020.
Frequently asked questions
What is the Incorporation or founding date of Grindlays Pharmaceuticals Pvt Ltd?
Grindlays Pharmaceuticals Pvt Ltd was incorporated on 04 Sep 1985.
What is authorized share capital and paid-up capital of Grindlays Pharmaceuticals Pvt Ltd?
The authorized share capital of Grindlays Pharmaceuticals Pvt Ltd is ₹ 1.00 Cr and paid-up capital is ₹ 1.00 Cr.
Who are the current board members & directors of Grindlays Pharmaceuticals Pvt Ltd?
Currently 4 directors are associated with Grindlays Pharmaceuticals Pvt Ltd.
- Santosh Ramkrishna Kolwankar
- Ramkrishna Harishet Kolwankar
- Dhanashri Girish Gudi
- Arti Ramkrishna Kolwankar
What is the registered address of Grindlays Pharmaceuticals Pvt Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Grindlays Pharmaceuticals Pvt Ltd is Office Number 406 407 408 4Th Floor Swastik Chambers Cst Road, Chembur India, Mumbai, Maharashtra, 400071.
What is the corporate identification number (CIN) and company number of Grindlays Pharmaceuticals Pvt Ltd?
The corporate identification number (CIN) of Grindlays Pharmaceuticals Pvt Ltd is U99999MH1985PTC037368 and the company number is 037368 as per Ministry of Corporate Affairs (MCA).
What is the official website of Grindlays Pharmaceuticals Pvt Ltd?
The Official website of Grindlays Pharmaceuticals Pvt Ltd is https://www.grinpharma.com
What has been the recent revenue trend for Grindlays Pharmaceuticals Pvt Ltd?
According to the financial reports for the fiscal year 2022, the revenue trend for Grindlays Pharmaceuticals Pvt Ltd has risen by 104.13%.
How many employees does Grindlays Pharmaceuticals Pvt Ltd currently have?
As Per 2022 financial reports, 12 employees are currently employed by Grindlays Pharmaceuticals Pvt Ltd.
What change has been observed in the net worth of Grindlays Pharmaceuticals Pvt Ltd, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Grindlays Pharmaceuticals Pvt Ltd has experienced an upsurge of 49.54%.
What are the total open charges for Grindlays Pharmaceuticals Pvt Ltd?
As per the financial statements for fiscal Year 2022, The total open charges for Grindlays Pharmaceuticals Pvt Ltd amount to ₹ 5.86 Cr.
When was the last Balance Sheet of Grindlays Pharmaceuticals Pvt Ltd filed with the ROC?
The most recent Balance Sheet for Grindlays Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records